Aggressive lymphoma: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Aggressive Lymphoma == | |||
{{Infobox medical condition | |||
| name = Aggressive lymphoma | |||
| image =[[File:Diffuse_large_B_cell_lymphoma_(3)_tonsil.jpg|250px]] | |||
| caption = Micrograph of [[Diffuse large B-cell lymphoma]], a type of aggressive lymphoma. [[H&E stain]]. | |||
| field = [[Hematology]] | |||
| symptoms = [[Lymphadenopathy]], [[fever]], [[night sweats]], [[weight loss]] | |||
| complications = [[Tumor lysis syndrome]], [[infection]], [[anemia]] | |||
| onset = Variable, often rapid | |||
| duration = Variable, can be chronic | |||
| types = [[Diffuse large B-cell lymphoma]], [[Burkitt lymphoma]], [[Mantle cell lymphoma]] | |||
| causes = Genetic mutations, [[Epstein-Barr virus]], [[HIV]] | |||
| risks = [[Immunosuppression]], [[autoimmune disease]], [[family history]] | |||
| diagnosis = [[Biopsy]], [[immunohistochemistry]], [[flow cytometry]] | |||
| differential = [[Indolent lymphoma]], [[reactive lymphadenopathy]], [[infection]] | |||
| prevention = None specific, manage risk factors | |||
| treatment = [[Chemotherapy]], [[radiation therapy]], [[stem cell transplant]] | |||
| prognosis = Variable, depends on type and stage | |||
| frequency = Common | |||
}} | |||
== Aggressive Lymphoma == | |||
'''Aggressive lymphoma''' refers to a group of fast-growing [[non-Hodgkin lymphoma|non-Hodgkin lymphomas]] that require prompt diagnosis and treatment. These lymphomas are characterized by rapid proliferation of malignant [[lymphocyte|lymphocytes]], leading to quickly enlarging [[lymph node|lymph nodes]] and potential involvement of extranodal sites. | '''Aggressive lymphoma''' refers to a group of fast-growing [[non-Hodgkin lymphoma|non-Hodgkin lymphomas]] that require prompt diagnosis and treatment. These lymphomas are characterized by rapid proliferation of malignant [[lymphocyte|lymphocytes]], leading to quickly enlarging [[lymph node|lymph nodes]] and potential involvement of extranodal sites. | ||
Latest revision as of 05:39, 4 April 2025
| Aggressive lymphoma | |
|---|---|
| File:Diffuse large B cell lymphoma (3) tonsil.jpg | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Lymphadenopathy, fever, night sweats, weight loss |
| Complications | Tumor lysis syndrome, infection, anemia |
| Onset | Variable, often rapid |
| Duration | Variable, can be chronic |
| Types | Diffuse large B-cell lymphoma, Burkitt lymphoma, Mantle cell lymphoma |
| Causes | Genetic mutations, Epstein-Barr virus, HIV |
| Risks | Immunosuppression, autoimmune disease, family history |
| Diagnosis | Biopsy, immunohistochemistry, flow cytometry |
| Differential diagnosis | Indolent lymphoma, reactive lymphadenopathy, infection |
| Prevention | None specific, manage risk factors |
| Treatment | Chemotherapy, radiation therapy, stem cell transplant |
| Medication | N/A |
| Prognosis | Variable, depends on type and stage |
| Frequency | Common |
| Deaths | N/A |
== Aggressive Lymphoma ==
Aggressive lymphoma refers to a group of fast-growing non-Hodgkin lymphomas that require prompt diagnosis and treatment. These lymphomas are characterized by rapid proliferation of malignant lymphocytes, leading to quickly enlarging lymph nodes and potential involvement of extranodal sites.
Types[edit]
Aggressive lymphomas include several subtypes, with the most common being:
Diffuse Large B-Cell Lymphoma (DLBCL)[edit]
DLBCL is the most prevalent form of aggressive lymphoma, accounting for approximately 30-40% of all cases. It typically presents with rapidly enlarging masses in lymph nodes or extranodal sites such as the gastrointestinal tract, central nervous system, or bone marrow.
Burkitt Lymphoma[edit]
Burkitt lymphoma is a highly aggressive B-cell lymphoma characterized by the translocation of the MYC oncogene. It is most commonly seen in children and young adults and is associated with Epstein-Barr virus in endemic forms.
Mantle Cell Lymphoma[edit]
Mantle cell lymphoma is a rare subtype of aggressive lymphoma that often presents with widespread disease, including lymphadenopathy, splenomegaly, and bone marrow involvement. It is characterized by the overexpression of cyclin D1 due to a translocation involving chromosomes 11 and 14.
Peripheral T-Cell Lymphoma[edit]
This is a heterogeneous group of aggressive lymphomas derived from mature T-cells. They often present with systemic symptoms such as fever, weight loss, and night sweats, along with lymphadenopathy and extranodal involvement.
Diagnosis[edit]
The diagnosis of aggressive lymphoma typically involves a combination of:
- Biopsy of affected tissue, often a lymph node, to obtain a histological diagnosis.
- Immunohistochemistry and flow cytometry to determine the specific subtype of lymphoma.
- Cytogenetic and molecular studies to identify characteristic genetic abnormalities.
Treatment[edit]
Treatment of aggressive lymphoma usually involves:
- Chemotherapy, often with regimens such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone).
- Radiation therapy in certain cases, particularly for localized disease.
- Stem cell transplantation for relapsed or refractory cases.
Prognosis[edit]
The prognosis for aggressive lymphoma varies depending on the specific subtype, stage at diagnosis, and response to treatment. DLBCL, for example, has a 5-year survival rate of approximately 60-70% with appropriate therapy.
Related Pages[edit]
Gallery[edit]
-
Diffuse large B-cell lymphoma in the tonsil
-
Burkitt lymphoma, touch prep, Wright stain
-
Diffuse large B-cell lymphoma in tonsil
-
Burkitt lymphoma, touch prep, Wright stain